[go: up one dir, main page]

DE11786796T8 - Antigenpeptid und verwendung davon - Google Patents

Antigenpeptid und verwendung davon Download PDF

Info

Publication number
DE11786796T8
DE11786796T8 DE11786796T DE11786796T DE11786796T8 DE 11786796 T8 DE11786796 T8 DE 11786796T8 DE 11786796 T DE11786796 T DE 11786796T DE 11786796 T DE11786796 T DE 11786796T DE 11786796 T8 DE11786796 T8 DE 11786796T8
Authority
DE
Germany
Prior art keywords
antigenpeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE11786796T
Other languages
English (en)
Other versions
DE11786796T1 (de
Inventor
Hasumi Kenichiro
Kuraya Mikio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE11786796T1 publication Critical patent/DE11786796T1/de
Application granted granted Critical
Publication of DE11786796T8 publication Critical patent/DE11786796T8/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE11786796T 2010-05-27 2011-05-23 Antigenpeptid und verwendung davon Active DE11786796T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39657410P 2010-05-27 2010-05-27
US396574P 2010-05-27
EP11786796.0A EP2430157B1 (de) 2010-05-27 2011-05-23 Antigenpeptid und verwendung davon

Publications (2)

Publication Number Publication Date
DE11786796T1 DE11786796T1 (de) 2013-03-21
DE11786796T8 true DE11786796T8 (de) 2013-04-25

Family

ID=45004081

Family Applications (1)

Application Number Title Priority Date Filing Date
DE11786796T Active DE11786796T8 (de) 2010-05-27 2011-05-23 Antigenpeptid und verwendung davon

Country Status (9)

Country Link
US (4) US8784830B2 (de)
EP (2) EP2430157B1 (de)
JP (2) JP5243624B2 (de)
CN (2) CN102471770B (de)
AU (1) AU2011259204B2 (de)
DE (1) DE11786796T8 (de)
MY (1) MY167069A (de)
SG (1) SG194420A1 (de)
WO (2) WO2011149099A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784830B2 (en) * 2010-05-27 2014-07-22 Kenichiro Hasumi Antigen peptide and use thereof
JP2012058530A (ja) * 2010-09-09 2012-03-22 Seiko Epson Corp シャッター眼鏡、及び、画像表示システム
CN104364394B (zh) 2012-03-17 2019-02-22 加州大学评议会 痤疮的快速诊断和个体化治疗
WO2017184992A1 (en) 2016-04-21 2017-10-26 Naked Biome, Inc. Compositions and methods for treatment of skin disorders
KR101873827B1 (ko) 2016-10-25 2018-07-03 주식회사 라파스 여드름 개선용 마이크로니들 패취 및 그 제조방법
CN115996754A (zh) 2020-02-21 2023-04-21 免疫之源生物技术有限公司 痤疮丙酸杆菌的预防性和治疗性免疫治疗
CN121285384A (zh) 2023-05-05 2026-01-06 赛诺菲巴斯德有限公司 用于在痤疮的治疗中使用的组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741262B1 (fr) * 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
JP2004520803A (ja) * 2000-04-21 2004-07-15 コリクサ コーポレイション 尋常性挫瘡の治療および診断のための組成物および方法
US7939567B2 (en) * 2006-02-24 2011-05-10 Blue Blood Biotech Corp. Dextromethorphan-based method for treating acne
US20120005773A1 (en) * 2008-10-01 2012-01-05 Aasen Eric D Transgenic plants with enhanced agronomic traits
CN102307562A (zh) * 2008-12-05 2012-01-04 加利福尼亚大学董事会 处理痤疮丙酸杆菌的方法和组合物
PH12012501991A1 (en) * 2010-04-07 2017-07-26 Abbvie Inc Tnf-alpha binding proteins
US8784830B2 (en) * 2010-05-27 2014-07-22 Kenichiro Hasumi Antigen peptide and use thereof

Also Published As

Publication number Publication date
JP2012528566A (ja) 2012-11-15
EP2430157A4 (de) 2012-07-04
US20180133299A1 (en) 2018-05-17
CN102471770A (zh) 2012-05-23
CN102471770B (zh) 2013-07-24
CN106687131A (zh) 2017-05-17
HK1168622A1 (en) 2013-01-04
US8784830B2 (en) 2014-07-22
EP3157554A4 (de) 2018-02-14
SG194420A1 (en) 2013-12-30
WO2011149099A1 (en) 2011-12-01
MY167069A (en) 2018-08-09
JP5243624B2 (ja) 2013-07-24
US10426825B2 (en) 2019-10-01
DE11786796T1 (de) 2013-03-21
EP3157554A1 (de) 2017-04-26
US11020468B2 (en) 2021-06-01
EP2430157B1 (de) 2013-05-08
US20150023997A1 (en) 2015-01-22
AU2011259204B2 (en) 2015-05-21
WO2015200254A1 (en) 2015-12-30
US9895432B2 (en) 2018-02-20
US20200009239A1 (en) 2020-01-09
US20120301495A1 (en) 2012-11-29
EP2430157A1 (de) 2012-03-21
JP2017520556A (ja) 2017-07-27

Similar Documents

Publication Publication Date Title
CY2021021I2 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
BR112012017441A2 (pt) compostos e métodos
LT2605789T (lt) Modifikuoti relaksino polipeptidai ir jų panaudojimas
HRP20160737T1 (hr) Anti-her3-protutijela i njihove uporabe
DK2552261T3 (da) Propfilter med proprum med aromakugle
EP3564380C0 (de) Rekombinante adenoviren und verwendung davon
DK2594567T3 (da) Heterocykliske alkynylbenzenforbindelser og anvendelser deraf
FI20105978A7 (fi) Tutkimusinstrumentti
BR112012031855A2 (pt) composição e artigo
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
DK2613884T3 (da) Findelingsindretning
ME02952B (de) Wnt-antagonisten sowie behandlungs- und screening-verfahren dafür
EP3470433C0 (de) Modifizierte antikörperregionen und verwendung davon
EP2547373A4 (de) Nanoröhren und zusammensetzung davon
EP2799437A4 (de) Chinolin- und cinnolinverbindungen und ihre verwendung
BR112012027165A2 (pt) composição e artigo
IL223667B (en) S100a4 antibodies and therapeutic uses thereof
EP2910563A4 (de) Triterpenderivat und dessen verwendung gegen grippe
BR112012028633A2 (pt) composição reticulada e artigo
DK2642992T3 (da) Forbindelser og anvendelse deraf
DE11786796T8 (de) Antigenpeptid und verwendung davon
EP2547464A4 (de) Anordnung und belüftungsanordnung
FR2964937B1 (fr) Triporteur et direction de triporteur
EP2762487A4 (de) Immunogene glutenpeptide und ihre verwendung
BR112012021749A2 (pt) processos e compostos